Board of Directors C. Geoffrey Davis, Ph.D. President and CEO Dr. Davis was a founder and the Chief Scientific Officer for Abgenix, Inc. in Fremont, California, where he led the development of the XenoMouse technology, was involved in the research and development of Vectabix, a fully human monoclona...

Research Programs The first fusion toxins were described in the literature in 1986. Since then, a large body of work has been published on fusion toxins based on a variety of bacterial toxins, including diphtheria, pseudomonas, and shigella, as well as plant toxins, including ricin, gelonin, and bou...

Contact Us Angelica Therapeutics, Inc. 1900 Powell Street, Suite 1050 Emeryville, CA 94608 C. Geoffrey Davis, Ph.D. President & CEO cell: 650.207.5605 email: gdavis@angther.com 2009 ANGELICA THERAPEUTICS, INC. COMPANY | DISEASE | PROGRAMS | CONTACT ...

Welcome to Angelica Therapeutics Angelica Therapeutics is an exciting young company focused on developing potent cancer therapeutics. We are building a pipeline of fusion toxins based on our proprietary new version of one of the most potent toxins known, Diphtheria toxin (DT). Fusion toxins are sing...